Company: LHI
Filing Date: 2025-02-14
Form Type: DRS/A
Source: 0001213900-25-014190
Chunk: 227

Company: Living Homeopathy International Ltd.
Filing Date: 2025-02-14
Form: DRS/A
Chunk 227
---
 Shares being offered. The underwriters propose initially to
offer the Class A Ordinary Shares to the public at the offering price set forth on the cover page of this prospectus and to dealers at
those prices less the aforesaid fee (“underwriting discount”) set forth on the cover page of this prospectus. If all of the
Class A Ordinary Shares offered by us are not sold at the offering price, the underwriters may change the offering price and other selling
terms by means of a supplement to this prospectus.

The following table shows the per share and total
IPO price, underwriting discounts, proceeds before expenses to us:

|                                                                                                  |     | Per      
 Ordinary 
 Share    |    |   |     | Total          
 without        
 exercise of    
 over-allotment 
 option         |    |   |     | Total            
 with             
 full exercise of 
 over-allotment   
 option           |    |   |
|:-------------------------------------------------------------------------------------------------|:----|:---------|:---|:--|:----|:---------------|:---|:--|:----|:-----------------|:---|:--|
| Initial                                                                                          
 Public Offering price (the midpoint of the range set forth on the cover page of this prospectus) |     | $        | [● | ] |     | $              | [● | ] |     |                  | [● | ] |
| Underwriting                                                                                     
 discounts (6.0%)                                                                                 |     | $        | [● | ] |     | $              | [● | ] |     |                  | [● | ] |
| Non-accountable expense allowance (1.0%)                                                         |     | $        | [● | ] |     | $              | [● | ] |     |                  | [● | ] |
| Proceeds,                                                                                        
 before expenses, to us                                                                           |     | $        | [● | ] |     | $              | [● | ] |     |                  | [● | ] |

| (1) | We have agreed to pay the Representative a discount equal to                                                                                      
 seven percent (6.0%) of the gross proceeds of this offering and each closing of the over-allotment option (if any) sourced by the Representative. |

| (2) | We also agreed to pay the Representative                                                                            
 a non-accountable expense allowance in the amount equal to one percent (1%) of the gross proceeds of this offering. |

<div align='center'>129</div